Publicaciones en las que colabora con CRISTINA JIMÉNEZ LUNA (15)

2023

  1. Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer

    International journal of nanomedicine, Vol. 18, pp. 5075-5093

  2. Curso de anatomía de tórax y abdomen para estudiantes de Biociencias

    Innovación docente e investigación en educación: nuevas tendencias para el cambio en la enseñanza superior (Dykinson), pp. 233-240

  3. Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review

    Metabolites, Vol. 13, Núm. 7

2022

  1. PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine

    Biomedicine and Pharmacotherapy, Vol. 155

2021

  1. Impact of the epigenetically regulated hoxa-5 gene in neural differentiation from human adipose-derived stem cells

    Biology, Vol. 10, Núm. 8

  2. Temozolomide: An updated overview of resistance mechanisms, nanotechnology advances and clinical applications

    Current Neuropharmacology, Vol. 19, Núm. 4, pp. 513-537

2020

  1. Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders

    Biomolecules and Therapeutics, Vol. 28, Núm. 1, pp. 34-44

  2. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

    Journal of Biosciences, Vol. 45, Núm. 1

  3. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

    AAPS PharmSciTech, Vol. 21, Núm. 5

2019

  1. O6-methylguanine-DNA methyltransferase promoter methylation in patients with rectal adenocarcinoma after chemoradiotherapy treatment: Clinical implications

    Balkan Medical Journal, Vol. 36, Núm. 5, pp. 283-286

  2. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

    Cancer Biology and Medicine, Vol. 16, Núm. 4, pp. 688-699

2016

  1. 73P Generation of miR-21 sponges in lung cancer treatment

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S86

  2. Last advances in nanocarriers-based drug delivery systems for colorectal cancer

    Current Drug Delivery, Vol. 13, Núm. 6, pp. 830-838

2014

  1. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34

  2. CO-17 Estudio de MGMT, MMR y P-gp como posibles meca-nismos de resistencia a la temozolamida en líneas tumoralesde glioblastoma

    I Congreso Nacional Multidisciplinar de Jóvenes Investigadores: libro de Actas : Facultad de Ciencias, Universidad de Granada 19, 20 y 21 de febrero de 2014 (Asociación de Investigadores Extranjeros (AINVEX)), pp. 55-59